Back to Results
First PageMeta Content
Diabetes / Peptide hormones / Recombinant proteins / Eli Lilly and Company / RTT / Insulin aspart / Insulin / Diabetes management / Diabetes mellitus type 1 / Glycated hemoglobin / Hyperglycemia / Insulin degludec


This material is intended for Canadian media only. Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoRap
Add to Reading List

Document Date: 2016-08-18 19:09:23


Open Document

File Size: 213,78 KB

Share Result on Facebook
UPDATE